Institut Jean Godinot
Reims, 51100, France
NCT Number: NCT03902964
observational monocentric study
Looking for future studies?
Notify Me18 year–80 year
Female
Observational
Reims, 51100, France
observational monocentric study
Primary objective :
Describe post-cancer supportive care needs, assessed by questionnaire in patients treated for breast cancer after completion of treatment and 2 years later.
Secondary objective :
Schedule :
The selected patients then received a letter including an information and non-objection note, the post-cancer needs questionnaire, the Fear Inventory severity subscale questionnaire, and the QLQ-C30 questionnaire. A delay of 1 month was chosen to return the questionnaire with a phone call after 15 days for an analysis of responses in February 2019.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Women who have been treated for breast cancer and whose treatment ended in 2017 (cohort A) and in 2015 (cohort B), aged between 18 and 80 years, and who declared their non-opposition free and enlightened.
Exclusion criteria
Patients who have been treated for recurrence or 2nd cancer, metastases from the outset, male, refusal to participate.
Time frame: 2 years
Post-cancer needs analysis based on the "post-cancer needs assessment" questionnaire for patients in both cohorts
Institut Jean-Godinot
Other
Acronym: EACE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05277935
Behavior, Breast Diseases
Rio de Janeiro, Brazil
View Trial DetailsNCT05969184
Breast Neoplasm Female
Beijing, Beijing Municipality, China
View Trial DetailsNCT03323346
Breast Diseases, Breast Neoplasm Female
Olomouc, Czechia
View Trial DetailsNCT05700006
Aging, Arthralgia
Ann Arbor, Michigan, United States
View Trial Details